Navigation Links
Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain
Date:1/28/2009

HONOLULU, Jan. 28 /PRNewswire/ -- Today at the American Academy of Pain Medicine's 25th Annual Meeting, researchers from University of California at San Diego report that no standardized practices exist for administering an epidural steroid injection for back pain. Researchers looked at many factors including: which steroids were given, the amount of steroid used, and whether or not a local anesthetic was mixed with the steroid.

Epidural steroid injections (ESI) are minimally invasive procedures used to treat pain in the neck, arms, back and legs caused by inflamed nerves. While injections in the lumbar (low back) region are low risk, injections in the thoracic (mid back) and cervical (neck) region have the risk of injury to the spinal cord and brain. It usually consists of a steroid diluted with sterile saline, and sometimes also addition of local anesthesia. Controversy exists on the long-term efficacy of this procedure to treat spine associated pain.

To compare currently taught techniques, Yogesh Patel, MD, and his colleagues at UCSD, identified and surveyed attending pain physicians at interventional pain programs in the United States about their protocols regarding ESI. Results showed that no standard protocols with regard to type of steroid, dose or use of local anesthesia exist. In fact, the data showed that while most physicians use a moderate volume and dose of steroid, some physicians are giving very high volumes (up to 10 cc) of steroids in areas such as the cervical epidural space. In limited enclosed areas like the cervical region that volume of medicine could lead to increased pressures which could potentially be painful for patients.

"Epidural steroid injections are an important and common option for the treatment of back pain. However, we found that a great variety of techniques are being used. There is no gold standard," said Dr. Patel, lead author of the
'/>"/>

SOURCE American Academy of Pain Medicine
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...alif., Nov. 25 Praxis Electronic M...e American Academy of Family Physicians, (AAFP) Fa...faction Survey for improving medical quality, heal...al for new ARRA Stimulus legislation. Praxis also ... positive effect in determining their salary. Fina...
(Date:11/25/2009)...A, Nov. 25 ERT (Nasdaq: ...vey, the Company,s President and CEO, and Keith Sc...CFO, are scheduled to present at the 21st Annual P... on December 1, 2009 in New York City, New York. ,...n by visiting the Company,s corporate website at ...
(Date:11/25/2009)...Md., Nov. 25 Remedium T...ream-like foam that stops severe bleeding, won fir...y Idea category of the Global Security Challenge 2...ted from more than 100 entries from around the wor... GSC Security Summit conference held at the London...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Gentiva 28R 29 Health Services to Present at the Credit Suisse Healthcare Conference 5927 1Gentiva 28R 29 Health Services to Present at the Credit Suisse Healthcare Conference 5927 2Gentiva 28R 29 Health Services to Present at the Credit Suisse Healthcare Conference 5927 3Kendle Appoints J Michael Sprafka MPH PhD Vice President Kendle Consulting 5923 1Kendle Appoints J Michael Sprafka MPH PhD Vice President Kendle Consulting 5923 2Kendle Appoints J Michael Sprafka MPH PhD Vice President Kendle Consulting 5923 3BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX 28GM CSF 29 in the Journal of Clinical Oncology 5919 1BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX 28GM CSF 29 in the Journal of Clinical Oncology 5919 2BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX 28GM CSF 29 in the Journal of Clinical Oncology 5919 3BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX 28GM CSF 29 in the Journal of Clinical Oncology 5919 4
(Date:11/29/2009)...oosts urine production, experts say , ,...ke up during the night to urinate shouldn,t automa... breathing-related sleep disorder, could be the ca...ation, or nocturia, is comparable to loud snoring ...r in which soft tissue in the throat blocks the fl...
(Date:11/28/2009)...ider change after 30-minute psychosocial intervent...althDay News) -- A program that gets persistent dr... dangerous behavior may lead to significant and lo...he new study included 184 men and women with two o...e randomly assigned to one of two interventions. T...
(Date:11/27/2009)...plikins Ltd. today issued its latest biochemical a...that the lethality of the virus has dropped from i...nt outbreak in the spring of 2009 to resting non-e...N1 infectivity count, however, remains increased. ... 27, 2009 -- Biotech firm Replikins Ltd., which ha...
(Date:11/27/2009)...7 Shamir Optical Industr...ovider of innovative products and technology to th... board of directors had declared a dividend distri...pproximately NIS 37.62 million based on the Novemb...pproximately US$ 0.609 (approximately NIS 2.3 base...
(Date:11/27/2009)...rade; announced today that Spectrum Health (Grand ...prise orthopedic templating solution and its Traum... (PRWEB) November 27, 2009 -- Voyant Health...d Rapids, Michigan) has licensed its TraumaCad Ent...umaCad Extend workflow solution, to allow its orth...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...ing to many studies pertaining to dental health a ...avities and is causing discoloured teeth.// T...nted at the American Association for Dental Resear...ch followed children from birth, starting in 1991-...
...han is considering of imposing a ban on the sale o...th of the children badly. With hot days round the ...pting for the chilled drinks. "The consumption...ted drinks in government-run schools," Ghanshyam T...
...in the blood thinner is not widely prescribed by t...k of stroke// and patients with abnormal heart rhy...ties. But the risk rates among them are the highes...study results were published in the journal Stroke...
...Health Organization and UNICEF conducted an intern...curring due to measles//. The results have proved ...% reduction. The global immunization drive was res...n estimated 454 000 by the end of 2004. Sub-Sahara...
Health products in Germany has grown in leaps and bounds as more and more health conscious Germans are willing to spend lavishly, be it for wellness//, sport, vitality or anti-ageing. The present tre
... feticide has become a common feature in the hill ...cides are carried out every year on an average//, ...the country. The shocking factor is that despite s...ale feticides every year, taking its gender ratio ...
Other Medicine News:Health News:Warfarin the Not So Popular Drug for Stroke 2Health News:Female Ratio Drops Alarmingly In Himachal Due To Feticides 2
Hudson Cranial Drill
Michele Vertebral Biopsy Trephine
Greenberg Universal Retractor Case
Greenberg Secondary Bar
Medicine Products: